Ionis Pharmaceuticals, Inc. Payments to Acquire Debt Securities, Available-for-sale
Ionis Pharmaceuticals, Inc. (IONS) reported Payments to Acquire Debt Securities, Available-for-sale of $513.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $320.25M, a 34.85% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $192.75M, a 38.03% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $791.97M, a 137.38% increase year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $323.94M, a 54.72% decline year-over-year.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2025 was $1.92B, a 3.55% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2024 was $1.85B, a 4.63% increase from fiscal 2023.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $1.77B, a 19.18% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $1.49B, a 32.16% increase from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $320.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $513.00M 10-Q · filed 2026-07-29 | $1.30B derived: sum of 3 quarters · filed 2026-07-29 | $1.63B derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $192.75M 10-Q · filed 2026-04-29 | $984.72M derived: sum of 2 quarters · filed 2026-04-29 | $1.31B derived: sum of 3 quarters · filed 2026-04-29 | $1.80B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $791.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.12B derived: sum of 2 quarters · filed 2026-02-26 | $1.61B derived: sum of 3 quarters · filed 2026-07-29 | $1.92B 10-K · filed 2026-02-26 |
| 2025-09-30 | $323.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $815.53M derived: sum of 2 quarters · filed 2026-07-29 | $1.13B 10-Q · filed 2025-10-29 | $1.46B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $491.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $802.66M 10-Q · filed 2026-07-29 | $1.14B derived: sum of 3 quarters · filed 2026-07-29 | $1.85B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $311.07M 10-Q · filed 2026-04-29 | $644.70M derived: sum of 2 quarters · filed 2026-04-29 | $1.36B derived: sum of 3 quarters · filed 2026-04-29 | $1.64B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $333.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.05B derived: sum of 2 quarters · filed 2026-02-26 | $1.33B derived: sum of 3 quarters · filed 2026-02-26 | $1.85B 10-K · filed 2026-02-26 |
| 2024-09-30 | $715.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.00B derived: sum of 2 quarters · filed 2025-10-29 | $1.52B 10-Q · filed 2025-10-29 | $1.94B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $284.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $803.87M 10-Q · filed 2025-07-30 | $1.22B derived: sum of 3 quarters · filed 2026-02-26 | $1.64B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $519.00M 10-Q · filed 2025-04-30 | $936.72M derived: sum of 2 quarters · filed 2026-02-26 | $1.36B derived: sum of 3 quarters · filed 2026-02-26 | $1.60B derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $417.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $838.45M derived: sum of 2 quarters · filed 2026-02-26 | $1.08B derived: sum of 3 quarters · filed 2026-02-26 | $1.77B 10-K · filed 2026-02-26 |
| 2023-09-30 | $420.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $664.82M derived: sum of 2 quarters · filed 2024-11-06 | $1.35B 10-Q · filed 2024-11-06 | $1.62B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $244.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $932.36M 10-Q · filed 2024-08-01 | $1.19B derived: sum of 3 quarters · filed 2025-02-19 | $1.75B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $688.28M 10-Q · filed 2024-05-07 | $950.26M derived: sum of 2 quarters · filed 2025-02-19 | $1.51B derived: sum of 3 quarters · filed 2025-02-19 | $1.71B derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $261.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $822.58M derived: sum of 2 quarters · filed 2025-02-19 | $1.02B derived: sum of 3 quarters · filed 2025-02-19 | $1.49B 10-K · filed 2025-02-19 |
| 2022-09-30 | $560.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $760.94M derived: sum of 2 quarters · filed 2023-11-02 | $1.22B 10-Q · filed 2023-11-02 | $1.42B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $200.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $663.20M 10-Q · filed 2023-08-09 | $856.42M derived: sum of 3 quarters · filed 2024-02-21 | $1.05B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $462.86M 10-Q · filed 2023-05-03 | $656.09M derived: sum of 2 quarters · filed 2024-02-21 | $846.33M derived: sum of 3 quarters · filed 2024-02-21 | $1.26B derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $193.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $383.47M derived: sum of 2 quarters · filed 2024-02-21 | $794.14M derived: sum of 3 quarters · filed 2024-02-21 | $1.12B 10-K · filed 2024-02-21 |
| 2021-09-30 | $190.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $600.91M derived: sum of 2 quarters · filed 2022-11-09 | $930.96M 10-Q · filed 2022-11-09 | $1.12B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $410.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $740.72M 10-Q · filed 2022-08-09 | $934.50M derived: sum of 3 quarters · filed 2023-02-22 | $1.33B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $330.05M 10-Q · filed 2022-05-04 | $523.83M derived: sum of 2 quarters · filed 2023-02-22 | $924.18M derived: sum of 3 quarters · filed 2023-02-22 | $1.36B derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $193.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $594.13M derived: sum of 2 quarters · filed 2023-02-22 | $1.03B derived: sum of 3 quarters · filed 2023-02-22 | $1.57B 10-K · filed 2023-02-22 |
| 2020-09-30 | $400.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $832.26M derived: sum of 2 quarters · filed 2021-11-03 | $1.38B 10-Q · filed 2021-11-03 | $1.71B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $431.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $976.28M 10-Q · filed 2021-08-04 | $1.31B derived: sum of 3 quarters · filed 2022-02-25 | $1.87B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $544.38M 10-Q · filed 2021-05-05 | $873.38M derived: sum of 2 quarters · filed 2022-02-25 | $1.44B derived: sum of 3 quarters · filed 2022-02-25 | $2.00B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $329.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $897.45M derived: sum of 2 quarters · filed 2022-02-25 | $1.45B derived: sum of 3 quarters · filed 2022-02-25 | $1.95B 10-K · filed 2022-02-25 |
| 2019-09-30 | $568.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $1.12B derived: sum of 2 quarters · filed 2020-11-04 | $1.62B 10-Q · filed 2020-11-04 | $2.26B derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $556.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.05B 10-Q · filed 2020-08-05 | $1.69B derived: sum of 3 quarters · filed 2021-02-24 | $2.20B derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $492.78M 10-Q · filed 2020-05-06 | $1.13B derived: sum of 2 quarters · filed 2021-02-24 | $1.64B derived: sum of 3 quarters · filed 2021-02-24 | $2.20B derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $638.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.15B derived: sum of 2 quarters · filed 2021-02-24 | $1.70B derived: sum of 3 quarters · filed 2021-02-24 | $1.79B 10-K · filed 2021-02-24 |
| 2018-09-30 | $507.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.07B derived: sum of 2 quarters · filed 2019-11-06 | $1.16B 10-Q · filed 2019-11-06 | $1.44B derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $557.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $648.90M 10-Q · filed 2019-08-08 | $937.06M derived: sum of 3 quarters · filed 2020-03-02 | $1.18B derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $91.16M 10-Q · filed 2019-05-09 | $379.31M derived: sum of 2 quarters · filed 2020-03-02 | $621.05M derived: sum of 3 quarters · filed 2020-03-02 | $702.78M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $288.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $529.89M derived: sum of 2 quarters · filed 2020-03-02 | $611.63M derived: sum of 3 quarters · filed 2020-03-02 | $877.81M 10-K · filed 2020-03-02 |
| 2017-09-30 | $241.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $323.47M derived: sum of 2 quarters · filed 2018-11-06 | $589.65M 10-Q · filed 2018-11-06 | $656.08M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $81.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $347.92M 10-Q · filed 2018-08-07 | $414.34M derived: sum of 3 quarters · filed 2019-03-01 | $567.01M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $266.19M 10-Q · filed 2018-05-07 | $332.61M derived: sum of 2 quarters · filed 2019-03-01 | $485.28M derived: sum of 3 quarters · filed 2019-03-01 | $525.73M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $66.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $219.10M derived: sum of 2 quarters · filed 2019-03-01 | $259.55M derived: sum of 3 quarters · filed 2019-03-01 | $300.91M 10-K · filed 2019-03-01 |
| 2016-09-30 | $152.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $193.12M derived: sum of 2 quarters · filed 2017-11-07 | $234.49M 10-Q · filed 2017-11-07 | $329.88M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $40.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $81.81M 10-Q · filed 2017-08-09 | $177.21M derived: sum of 3 quarters · filed 2018-02-28 | $334.71M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $41.37M 10-Q · filed 2017-05-09 | $136.76M derived: sum of 2 quarters · filed 2018-02-28 | $294.26M derived: sum of 3 quarters · filed 2018-02-28 | $494.62M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $95.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $252.90M derived: sum of 2 quarters · filed 2018-02-28 | $453.25M derived: sum of 3 quarters · filed 2018-02-28 | $493.47M 10-K · filed 2018-02-28 |
| 2015-09-30 | $157.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $357.86M derived: sum of 2 quarters · filed 2016-11-09 | $398.08M 10-Q · filed 2016-11-09 | $539.38M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $200.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $240.57M 10-Q · filed 2016-08-09 | $381.87M derived: sum of 3 quarters · filed 2017-03-01 | $453.26M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $40.21M 10-Q · filed 2016-05-05 | $181.52M derived: sum of 2 quarters · filed 2017-03-01 | $252.90M derived: sum of 3 quarters · filed 2017-03-01 | $362.91M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $141.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $212.69M derived: sum of 2 quarters · filed 2017-03-01 | $322.70M derived: sum of 3 quarters · filed 2017-03-01 | $391.88M 10-K · filed 2017-03-01 |
| 2014-09-30 | $71.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $181.40M derived: sum of 2 quarters · filed 2015-11-09 | $250.58M 10-Q · filed 2015-11-09 | $372.27M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $110.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $179.20M 10-Q · filed 2015-08-05 | $300.89M derived: sum of 3 quarters · filed 2016-02-26 | $460.50M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $69.19M 10-Q · filed 2015-05-05 | $190.88M derived: sum of 2 quarters · filed 2016-02-26 | $350.49M derived: sum of 3 quarters · filed 2016-02-26 | $430.19M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $121.69M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $281.30M derived: sum of 2 quarters · filed 2016-02-26 | $361.00M derived: sum of 3 quarters · filed 2016-02-26 | $425.55M 10-K · filed 2016-02-26 |
| 2013-09-30 | $159.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $239.31M derived: sum of 2 quarters · filed 2014-11-07 | $303.86M 10-Q · filed 2014-11-07 | $349.16M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $79.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $144.25M 10-Q · filed 2014-08-04 | $189.55M derived: sum of 3 quarters · filed 2015-03-02 | $245.47M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $64.55M 10-Q · filed 2014-05-06 | $109.85M derived: sum of 2 quarters · filed 2015-03-02 | $165.78M derived: sum of 3 quarters · filed 2015-03-02 | $220.59M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $45.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $101.22M derived: sum of 2 quarters · filed 2015-03-02 | $156.04M derived: sum of 3 quarters · filed 2015-03-02 | $217.88M 10-K · filed 2015-03-02 |
| 2012-09-30 | $55.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $110.74M derived: sum of 2 quarters · filed 2013-11-05 | $172.58M 10-Q · filed 2013-11-05 | $259.31M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $54.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $116.65M 10-Q · filed 2013-08-06 | $203.38M derived: sum of 3 quarters · filed 2014-03-03 | $279.04M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $61.84M 10-Q · filed 2013-05-07 | $148.57M derived: sum of 2 quarters · filed 2014-03-03 | $224.23M derived: sum of 3 quarters · filed 2014-03-03 | $322.79M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $86.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $162.38M derived: sum of 2 quarters · filed 2014-03-03 | $260.94M derived: sum of 3 quarters · filed 2014-03-03 | $371.11M 10-K · filed 2014-03-03 |
| 2011-09-30 | $75.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $174.22M derived: sum of 2 quarters · filed 2012-11-06 | $284.38M 10-Q · filed 2012-11-06 | $384.88M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $98.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $208.72M 10-Q · filed 2012-08-06 | $309.23M derived: sum of 3 quarters · filed 2013-02-28 | $412.70M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $110.16M 10-Q · filed 2012-05-09 | $210.67M derived: sum of 2 quarters · filed 2013-02-28 | $314.14M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | $100.51M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $203.97M derived: sum of 2 quarters · filed 2013-02-28 | $530.14M 10-K · filed 2013-02-28 | |
| 2010-09-30 | $103.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $429.63M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $326.16M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $776.38M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |